January 19, 2021
Celgene Headquarters

Celgene Board of Directors Compensation, and Salary [Stock Options etc..]

Celgene is a famous pharmaceutical company, headquartered in Summit, New Jersey, United States. The company was initially incorporated in Delaware, United States. They have more than 8K employees as of 2018. The company is lead by CEO Mark J. Alles since March 2016.

In this article, we have provided Celgene board of directors total compensation and executives salary. So, let’s see!

Celgene Headquarters
Celgene Headquarters

Celgene Board of Directors Total Compensation Year Ended 2018

Richard W. Barker, D.Phil., OBE – Director of the Centre for Accelerating Medical Innovations

This board member earned US$537,506 ​as total compensation including cash salary US$90,000, Stock Awards US$112,511, and Option Awards US$334,996.

Hans Bishop – Former CEO of Juno Therapeutics, Inc.

This board member earned US$800,055 ​as total compensation including cash salary US$52,747, Stock Awards US$112,511, and Option Awards US$634,798.

Michael W. Bonney – CEO and Chairman of the Board of Kaleido Biosciences, Inc.

This board member earned US$535,748 ​as total compensation including cash salary US$88,242, Stock Awards US$112,511, and Option Awards US$334,996.

Michael D. Casey – Independent Lead Director of Celgene Corporation and Director of Abaxis, Inc.

This board member earned US$590,006 ​as total compensation including cash salary US$142,500, Stock Awards US$112,511, and Option Awards US$334,996.

Carrie S. Cox – Chairman of the Board and Chief Executive Officer of Humacyte, Inc.

This board member earned US$535,748 ​as total compensation including cash salary US$88,242, Stock Awards US$112,511, and Option Awards US$334,996.

Michael A. Friedman, M.D. – Emeritus Chief Executive Officer of City of Hope

This board member earned US$530,006 ​as total compensation including cash salary US$82,500, Stock Awards US$112,511, and Option Awards US$334,996.

Julia A. Haller, M.D. – Ophthalmologist-in-Chief of the Wills Eye Hospital

This board member earned US$537,506 ​as total compensation including cash salary US$90,000, Stock Awards US$112,511, and Option Awards US$334,996.

Patricia Hemingway Hall – Former CEO of Health Care Service Corporation

This board member earned US$811,107 ​as total compensation including cash salary US$63,503, Stock Awards US$112,511, and Option Awards US$635,094.

Robert J. Hugin

This board member earned US$422,343 ​as total compensation.

Gilla Kaplan, Ph.D.

This board member earned US$41,250 ​as total compensation including cash salary US$41,250.

James J. Loughlin – Former National Director of the Pharmaceuticals Practice at KPMG LLP 

This board member earned US$565,006 ​as total compensation including cash salary US$117,500, Stock Awards US$112,511, and Option Awards US$334,996.

Ernest Mario, Ph.D. – Chairman of the Board of Soleno Therapeutics, Inc. and Chimerix, Inc.

This board member earned US$560,006 ​as total compensation including cash salary US$112,500, Stock Awards US$112,511, and Option Awards US$334,996.

John H. Weiland – Former President and COO of C.R. Bard, Inc.

This board member earned US$822,312 ​as total compensation including cash salary US$77,414, Stock Awards US$112,511, and Option Awards US$632,387.

Celgene Board of Directors Total Compensation Year Ended 2017

Richard W. Barker, D.Phil., OBE – Director of the Centre for Accelerating Medical Innovations

This board member earned US$525,470 ​as total compensation including cash salary US$90,000, RSU awards US$108,936, and Option Awards US$ 326,534.

​ Michael W. Bonney – CEO and Chairman of the Board of Kaleido Biosciences, Inc.

This board member earned US$525,470 as total compensation including cash salary US$90,000, RSU awards US$108,936, and Option Awards US$ 326,534.

Michael D. Casey – Independent Lead Director of Celgene Corporation and Director of Abaxis, Inc.

This board member earned US$577,970 as total compensation including cash salary US$142,500, RSU awards US$108,936, and Option Awards US$326,534.

Carrie S. Cox – Chairman of the Board and Chief Executive Officer of Humacyte, Inc.

This board member earned US$525,470 as total compensation including cash salary US$90,000, RSU awards US$108,936, and Option Awards US$326,534.

​ Michael A. Friedman, M.D. – Emeritus Chief Executive Officer of City of Hope

This board member earned US$517,970 as total compensation including cash salary US​$82,500, RSU awards US$108,936, and Option Awards US$326,534.

Julia A. Haller, M.D. – Ophthalmologist-in-Chief of the Wills Eye Hospital

This board member earned US$525,470 as total compensation including cash salary US$90,000, RSU awards US$108,936, and Option Awards US$326,534.

​ Gilla Kaplan, Ph.D. ​ ​ 

This board member earned US$517,970 as total compensation including cash salary US$82,500, RSU awards US$108,936, and Option Awards US$326,534.

​ James J. Loughlin – Former National Director of the Pharmaceuticals Practice at KPMG LLP

This board member earned US$552,970 as total compensation including cash salary US$117,500, RSU awards US$ 108,936, and Option Awards US$326,534.

​ Ernest Mario, Ph.D. – Chairman of the Board of Soleno Therapeutics, Inc. and Chimerix, Inc.

This board member earned US$547,970 as total compensation including cash salary US$112,500, RSU awards US$ 108,936, and Option Awards US$326,534.

Read Related Article Also: CVS Health Board of Directors Salaries

Article last re-published on December 20, 2020.